Crystal structures of calpain-E64 and -leupeptin inhibitor complexes reveal mobile loops gating the active site

Journal of Molecular Biology

Volumn 343, Issue 5, 2004, Pages 1313-1326

  Moldoveanu, T ^a   Campbell, R L ^a   Cuerrier, D ^a   Davies, P L ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

calcium; calpain; cysteine protease inhibitors; X ray crystallography

Indexed keywords

CALPAIN; CYSTEINE PROTEINASE; ISOPROTEIN; LEUPEPTIN; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE; PAPAIN;

ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; MOLECULAR WEIGHT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN STRUCTURE; STRUCTURE ANALYSIS;

EID: 6344285318     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2004.09.016     Document Type: Article

References (45)

1. H. Sorimachi, S. Ishiura, and K. Suzuki Structure and physiological function of calpains Biochem. J. 328 1997 721 732
2. D.E. Goll, V.F. Thompson, H. Li, W. Wei, and J. Cong The calpain system Physiol. Rev. 83 2003 731 801
3. H. Sorimachi, and K. Suzuki The structure of calpain J. Biochem. (Tokyo) 129 2001 653 664
4. A. Glading, D.A. Lauffenburger, and A. Wells Cutting to the chase: calpain proteases in cell motility Trends Cell. Biol. 12 2002 46 54
5. K.K. Wang Calpain and caspase: can you tell the difference? Trends Neurosci. 23 2000 20 26
6. L. Santella, K. Kyozuka, L. De Riso, and E. Carafoli Calcium, protease action, and the regulation of the cell cycle Cell Calcium 23 1998 123 130
7. K.K. Wang, and P.W. Yuen Development and therapeutic potential of calpain inhibitors Advan. Pharmacol. 37 1997 117 152
8. K.K. Wang, and P.W. Yuen Calpain inhibition: an overview of its therapeutic potential Trends Pharmacol. Sci. 15 1994 412 419
9. Y. Huang, and K.K. Wang The calpain family and human disease Trends Mol. Med. 7 2001 355 362
10. X. Liu, T. Van Vleet, and R.G. Schnellmann The role of calpain in oncotic cell death Annu. Rev. Pharmacol. Toxicol. 44 2004 349 370
11. G.N. Patrick, L. Zukerberg, M. Nikolic, S. de la Monte, P. Dikkes, and L.H. Tsai Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration Nature 402 1999 615 622
12. M.S. Lee, Y.T. Kwon, M. Li, J. Peng, R.M. Friedlander, and L.H. Tsai Neurotoxicity induces cleavage of p35 to p25 by calpain Nature 405 2000 360 364
13. M.S. Lee, and L.H. Tsai Cdk5: one of the links between senile plaques and neurofibrillary tangles? J. Alzheimers Dis. 5 2003 127 137
14. I.O. Donkor A survey of calpain inhibitors Curr. Med. Chem. 7 2000 1171 1188
15. M. Maki, H. Ma, E. Takano, Y. Adachi, W.J. Lee, M. Hatanaka, and T. Murachi Calpastatins: biochemical and molecular biological studies Biomed. Biochim. Acta 50 1991 509 516
16. M. Laval, and M. Pascal A calpain-like activity insensitive to calpastatin in Drosophila melanogaster Biochim. Biophys. Acta 1570 2002 121 128
17. B. Todd, D. Moore, C.C. Deivanayagam, G.D. Lin, D. Chattopadhyay, and M. Maki A structural model for the inhibition of calpain by calpastatin: crystal structures of the native domain VI of calpain and its complexes with calpastatin peptide and a small molecule inhibitor J. Mol. Biol. 328 2003 131 146
18. C.M. Hosfield, Q. Ye, J.S. Arthur, C. Hegadorn, D.E. Croall, J.S. Elce, and Z. Jia Crystallization and X-ray crystallographic analysis of m-calpain, a Ca2+-dependent protease Acta Crystallog. sect. D Biol Crystallog. 55 1999 1484 1486
19. S. Strobl, C. Fernandez-Catalan, M. Braun, R. Huber, H. Masumoto, and K. Nakagawa The crystal structure of calcium-free human m-calpain suggests an electrostatic switch mechanism for activation by calcium Proc. Natl Acad. Sci. USA 97 2000 588 592
20. D. Reverter, M. Braun, C. Fernandez-Catalan, S. Strobl, H. Sorimachi, and W. Bode Flexibility analysis and structure comparison of two crystal forms of calcium-free human m-calpain Biol. Chem. 383 2002 1415 1422
21. G.P. Pal, J.S. Elce, and Z. Jia Dissociation and aggregation of calpain in the presence of calcium J. Biol. Chem. 276 2001 47233 47238
22. T. Moldoveanu, C.M. Hosfield, D. Lim, J.S. Elce, Z. Jia, and P.L. Davies A Ca(2+) switch aligns the active site of calpain Cell 108 2002 649 660
23. K. Saito, and R.A. Nixon Specificity of calcium-activated neutral proteinase (CANP) inhibitors for human mu CANP and mCANP Neurochem. Res. 18 1993 231 233
24. T. Moldoveanu, Z. Jia, and P.L. Davies Calpain activation by cooperative Ca2+ binding at two non-EF-hand sites J. Biol. Chem. 279 2004 6106 6114
25. D. Turk, G. Guncar, M. Podobnik, and B. Turk Revised definition of substrate binding sites of papain-like cysteine proteases Biol. Chem. 379 1998 137 147
26. B.G. Diaz, T. Moldoveanu, M.J. Kuiper, R.L. Campbell, and P.L. Davies Insertion sequence 1 of muscle-specific calpain, p94, acts as an internal propeptide J. Biol. Chem. 279 2004 27656 27666
27. D. Turk, and G. Guncar Lysosomal cysteine proteases (cathepsins): promising drug targets Acta Crystallog. sect. D Biol. Crystallog. 59 2003 203 213
28. D. Turk, B. Turk, and V. Turk Papain-like lysosomal cysteine proteases and their inhibitors: drug discovery targets? Biochem. Soc. Symp. 2003 15 30
29. F. Lecaille, J. Kaleta, and D. Bromme Human and parasitic papain-like cysteine proteases: their role in physiology and pathology and recent developments in inhibitor design Chem. Rev. 102 2002 4459 4488
30. M.E. McGrath The lysosomal cysteine proteases Annu. Rev. Biophys. Biomol. Struct. 28 1999 181 204
31. I.G. Kamphuis, K.H. Kalk, M.B. Swarte, and J. Drenth Structure of papain refined at 1.65 Å resolution J. Mol. Biol. 179 1984 233 256
32. E. Schroder, C. Phillips, E. Garman, K. Harlos, and C. Crawford X-ray crystallographic structure of a papain-leupeptin complex FEBS Letters 315 1993 38 42
33. B. Zhao, C.A. Janson, B.Y. Amegadzie, K. D'Alessio, C. Griffin, and C.R. Hanning Crystal structure of human osteoclast cathepsin K complex with E-64 Nature Struct. Biol. 4 1997 109 111
34. P. Tompa, P. Buzder-Lantos, A. Tantos, A. Farkas, A. Szilagyi, and Z. Banoczi On the sequential determinants of calpain cleavage J. Biol. Chem. 279 2004 20775 20785
35. T. Moldoveanu, C.M. Hosfield, D. Lim, Z. Jia, and P.L. Davies Calpain silencing by a reversible intrinsic mechanism Nature Struct. Biol. 10 2003 371 378
36. Z. Otwinowski, and W. Minor Processing of X-ray diffraction data collected in oscillation mode Methods Enzymol. 276 1997 307 326
37. Collaborative Computational Project Number 4 The CCP4 suite: progams for protein crystallography Acta Crystallog. sect. D 50 1994 760 763
38. J. Navaza AMoRe: an automated package for molecular replacement Acta Crystallog. sect. A 50 1994 157 163
39. A.T. Brünger Crystallography and NMR system: a new software system for macromolecular structure determination Acta Crystallog. sect. D 45 1998 905 921
40. D.E. McRee A visual protein crystallographic software system for X11/XView J. Mol. Graph. 10 1992 44 46
41. DeLano, W. L. (2003). "The PyMOL Molecular Graphics System" DeLano Scentific LLC, San Carlos, CA, USA. http://www.pymol.org, San Carlos.
42. E.A. Merritt, and D.J. Bacon RASTER3D: photorealistic molecular graphics Methods Enzymol. 277 1997 505 524
43. G.E. Cohen ALIGN: a program to superimpose protein coordinates, accounting for insertions and deletions J. Appl. Crystallog. 30 1997 1160 1161
44. J.D. Thompson, D.G. Higgins, and T.J. Gibson CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice Nucl. Acids Res. 22 1994 4673 4680
45. Z. Jia, S. Hasnain, T. Hirama, X. Lee, J.S. Mort, R. To, and C.P. Huber Crystal structures of recombinant rat cathepsin B and a cathepsin B-inhibitor complex: implications for structure-based inhibitor design J. Biol. Chem. 270 1995 5527 5533